Tier I Canada Research Chair In Interfacial Biotechnology

加拿大一级界面生物技术研究主席

• 批准号: CRC-2014-00045
• 负责人: Haynes, Charles
• 金额: $ 14.57万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Canada Research Chairs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=729467
• 关键词: Tier; Canada; Research; Chair; Interfacial

The ongoing research program of Dr. Haynes, which aligns closely to the needs of the biotechnology industry, as well as the equipment and reagent manufacturers that serve that industry, will provide fundamental and operational advances to the instrumentation and methods currently used to manufacture therapeutic proteins and oligonucleotides. These advances will include novel chromatographic media and methods for high-resolution purification of protein therapeutics at manufacturing scales, and technological advances in instruments and assays used by clinics and hospitals to detect and quantify genetic targets integral to the proper diagnosis and treatment of disease, most notably various life-threatening forms of cancer.

Haynes博士正在进行的研究计划与生物技术行业以及服务于该行业的设备和试剂制造商的需求密切相关，将为目前用于制造治疗性蛋白质和寡核苷酸的仪器和方法提供基础和操作方面的进步。 这些进展将包括新的色谱介质和方法，用于在生产规模上高分辨率纯化蛋白质治疗剂，以及诊所和医院用于检测和量化遗传靶点的仪器和测定的技术进步，这些靶点是疾病的正确诊断和治疗所不可或缺的，最值得注意的是各种危及生命的癌症形式。